United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
Go back to United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 544.33 +6.03 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $538.30 | 52 Week High | $164.04 | |||
| Open | $542.08 | 52 Week Low | $97.52 | |||
| Day High | $546.58 | P/E | 99.51 | |||
| Day Low | $539.70 | EPS | $5.47 | |||
| Volume | 792,809 | |||||
